Dicyclomine HydrochlorideThird Party Manufacturing in India

Dicyclomine Hydrochloride works by blocking the action of acetylcholine on muscarinic receptors located specifically on the smooth muscle cells of the gastrointestinal tract.

By binding competitively to these specific receptors, it prevents acetylcholine from initiating intracellular calcium release, which is required for muscle contractions. This biological effect directly relaxes the smooth muscle of the stomach, small intestine, and colon, thereby reducing painful muscle spasms and hypermotility. Additionally, it exhibits a direct, non-specific spasmolytic effect on the smooth muscle cells themselves, which further helps relieve abdominal cramps and colicky pain without relying solely on receptor-specific blockade.

Unlike general systemic anticholinergic medications, Dicyclomine Hydrochloride targets the digestive tract with high specificity, which helps minimize common systemic side effects like dry mouth or blurred vision. It is a highly effective, well-tolerated option for patients suffering from severe abdominal cramping, spasms, and pain related to functional bowel disorders such as irritable bowel syndrome.

Therapeutic Uses

Dicyclomine Hydrochloride is prescribed for the treatment of:

• Irritable Bowel Syndrome (IBS): Relief of abdominal pain, cramping, and spasms associated with functional bowel disturbances.
• Acute Gastrointestinal Spasms: Treatment of severe muscle spasms of the gastrointestinal tract, promoting muscle relaxation.
• Infantile Colic: Used under strict pediatric supervision as an oral solution to soothe persistent intestinal spasms in infants.
• Biliary and Renal Colic: Adjunctive therapy in managing acute pain associated with spasms in the biliary or urinary tract.

Why Manufacturers Choose Dicyclomine Hydrochloride

Dicyclomine Hydrochloride is a highly popular antispasmodic molecule with a long history of therapeutic success. It is widely manufactured in India in both oral forms (tablets and syrups) and sterile injectable forms (10mg/ml and 20mg/2ml) for acute care. Sourcing this molecule from a WHO-GMP certified manufacturer ensures compliance with international quality standards and guarantees the absence of active impurities in both the API and finished formulations.

For pharmaceutical companies, Dicyclomine Hydrochloride represents a stable, high-demand molecule that fits perfectly into gastrointestinal and general medicine product portfolios.

This makes Dicyclomine Hydrochloride one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.